Evrysdi boosts motor function, quality of life in Asian SMA patients
WHY IT MATTERS
This real-world evidence from Asian patients shows Evrysdi works well outside of clinical trials, which may help doctors decide if it's the right treatment for SMA patients in your region.
A study of 34 patients in Hong Kong found that Evrysdi (a medicine taken by mouth) helped children and adults with spinal muscular atrophy (SMA) move better and feel better in their daily lives. Patients who had never taken SMA medicine before saw the biggest improvements. The good results lasted for up to three years.
Treatment with Evrysdi (risdiplam) improved motor function and quality of life in children and adults with spinal muscular atrophy (SMA), a real-world study in Hong Kong shows. The findings, from 34 patients followed for up to three years, showed clinically meaningful gains in motor and upper-limb function, particularly in treatment-naïve patients, along with a generally favorable […] The post Evrysdi boosts motor function, quality of life in Asian SMA patients appeared first on SMA News T
ASK YOUR DOCTOR
If you or a family member has SMA and haven't started treatment yet, ask your doctor whether Evrysdi might be an option and how it compares to other available treatments.